Acyclovir is NOT appropriate for treating typical bacterial pneumonia
Acyclovir is only indicated for pneumonia caused by specific herpes viruses (HSV, VZV), not for bacterial or typical viral pneumonia. The drug has no activity against common respiratory pathogens that cause pneumonia.
When Acyclovir IS Appropriate for Pneumonia
Herpes Simplex Virus (HSV) Pneumonia
- Confirmed or suspected HSV pneumonia requires IV acyclovir 5-10 mg/kg every 8 hours 1
- Consider in immunocompromised patients with progressive pneumonia not responding to antibiotics
- One study showed improved ICU survival in ventilated patients with high HSV viral loads (>10^5 copies/mL) and antibiotic-refractory pneumonia when treated with acyclovir 2
- Diagnosis requires detection of HSV in respiratory secretions via PCR or culture
Varicella-Zoster Virus (VZV) Pneumonia
- IV acyclovir 10-15 mg/kg three times daily is recommended 3
- Early treatment (within 36 hours) in otherwise healthy adults with varicella pneumonia significantly reduces fever, respiratory rate, and improves oxygenation by day 5-6 4
- All adults with varicella pneumonia should receive IV acyclovir promptly 5
- Consider adding corticosteroids for severe cases with marked respiratory compromise 3, 5
When Acyclovir is NOT Appropriate
Bacterial Pneumonia (Community-Acquired)
- Standard bacterial pneumonia requires antibiotics targeting S. pneumoniae, H. influenzae, and S. aureus 6
- Preferred regimens: co-amoxiclav, cephalosporins (cefuroxime/cefotaxime), or respiratory fluoroquinolones
- Acyclovir has zero antibacterial activity
Influenza Pneumonia
- Neuraminidase inhibitors (oseltamivir, zanamivir) are appropriate for influenza, not acyclovir 1
- Treatment must begin within 48 hours of symptom onset
- Bacterial superinfection requires antibiotics covering S. pneumoniae, S. aureus, H. influenzae 1
Other Viral Pneumonias
- No established efficacy for RSV, parainfluenza, adenovirus, or coronavirus pneumonia 1
- Cytomegalovirus (CMV) pneumonia: High-dose acyclovir showed no benefit in bone marrow transplant patients 7
Critical Caveats
Immunocompromised Patients
- HSV reactivation is common in mechanically ventilated ICU patients
- Only treat if high viral load (>10^5 copies/mL) AND failure to respond to appropriate antibiotics 2
- Routine prophylaxis not recommended without documented infection 8
Dosing and Safety
- Must be given as slow IV infusion over ≥1 hour to prevent renal tubular damage 9
- Ensure adequate hydration during administration
- Adjust dose for renal impairment (creatinine clearance <50 mL/min)
- Monitor for nephrotoxicity, encephalopathy (1% incidence), and TTP/HUS in immunocompromised patients 9
Diagnostic Requirements
- Do not empirically treat pneumonia with acyclovir
- Requires microbiologic confirmation (PCR, culture, serology) of herpes virus infection
- Blood and sputum cultures should be obtained to rule out bacterial pathogens 10
Bottom Line Algorithm
- Is this bacterial pneumonia? → Use antibiotics (co-amoxiclav, cephalosporins, fluoroquinolones), NOT acyclovir
- Is this influenza? → Use oseltamivir/zanamivir within 48 hours, NOT acyclovir
- Is this confirmed/suspected HSV or VZV pneumonia? → Use IV acyclovir 5-10 mg/kg q8h (HSV) or 10-15 mg/kg q8h (VZV)
- Immunocompromised with ventilator-associated pneumonia failing antibiotics? → Test for HSV; if high viral load, consider acyclovir 2
Acyclovir is a highly specific antiviral with a narrow indication in pneumonia—reserve it exclusively for documented herpes virus infections of the lung.